AGÕæÈ˹ٷ½

STOCK TITAN

[6-K] PolyPid Ltd. Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K
Rhea-AI Filing Summary

PolyPid Ltd. submitted a Form 6-K dated August 13, 2025, furnishing its unaudited interim condensed financial statements and management's discussion and analysis for the six months ended June 30, 2025. The filing includes XBRL-formatted financial information covering interim condensed consolidated balance sheets, statements of operations, shareholders' equity, cash flows and notes, plus an embedded Cover Page Interactive Data File. The report is submitted by the Chief Executive Officer and lists related exhibit numbers for the financial statements, MD&A and XBRL tagging.

PolyPid Ltd. ha presentato un Modulo 6-K datato 13 agosto 2025, fornendo i suoi bilanci interinali abbreviati non revisionati e la relazione e analisi della direzione per i sei mesi terminati il 30 giugno 2025. La segnalazione include informazioni finanziarie in formato XBRL che coprono gli stati patrimoniali consolidati interinali abbreviati, i rendiconti economici, il prospetto del patrimonio netto, il rendiconto finanziario e le note, oltre a un file dati interattivo della pagina di copertina incorporato. Il rapporto è presentato dall'Amministratore Delegato e riporta i numeri di riferimento degli allegati relativi ai bilanci, alla MD&A e al tagging XBRL.

PolyPid Ltd. presentó un Formulario 6-K con fecha 13 de agosto de 2025, proporcionando sus estados financieros interinos condensados no auditados y la discusión y análisis de la gerencia correspondientes a los seis meses concluídos el 30 de junio de 2025. La presentación incluye información financiera en formato XBRL que abarca balances consolidados interinos condensados, estados de resultados, patrimonio de los accionistas, flujos de efectivo y notas, además de un Archivo de Datos Interactivo de la Página de Portada incrustado. El informe lo presenta el Director Ejecutivo y lista los números de los anexos relacionados con los estados financieros, la MD&A y el etiquetado XBRL.

PolyPid Ltd.ëŠ� 2025ë…� 8ì›� 13ì¼ìž Form 6-Kë¥� 제출하여 2025ë…� 6ì›� 30ì¼ë¡œ 종료ë˜ëŠ” 6개월 기간ì—� 대í•� 검토ë˜ì§€ ì•Šì€ ì¤‘ê°„ 요약 ìž¬ë¬´ì œí‘œì™¶Ä ê²½ì˜ì§„ì˜ ë…¼ì˜ ë°� ë¶„ì„(MD&A)ì� 제공했습니다. 해당 서류ì—는 중간 요약 ì—°ê²° 대차대조표, ì†ìµê³„ì‚°ì„�, ìžë³¸ ë³€ë™í‘œ, 현금í름í‘� ë°� 주ì„ì� í¬í•¨í•� XBRL 형ì‹ì� ìž¬ë¬´ì •ë³´ì™¶Ä í¬í•¨ë� 표지 페ì´ì§€ ì¸í„°ëž™í‹°ë¸� ë°ì´í„� 파ì¼ì� í¬í•¨ë˜ì–´ 있습니다. 보고서는 최고경ì˜ìžê°€ 제출했으ë©� 재무제표, MD&A ë°� XBRL 태깅 ê´€ë � 전시ë¬� 번호ë¥� 명시하고 있습니다.

PolyPid Ltd. a déposé un formulaire 6-K daté du 13 août 2025, fournissant ses états financiers intermédiaires condensés non audités et la discussion et analyse de la direction pour les six mois clos le 30 juin 2025. le dépôt comprend des informations financières au format XBRL couvrant les bilans consolidés intermédiaires condensés, les comptes de résultat, les capitaux propres, les flux de trésorerie et les notes, ainsi qu'un fichier de données interactif de la page de couverture intégré. Le rapport est soumis par le directeur général et indique les numéros des annexes relatifs aux états financiers, à la MD&A et au balisage XBRL.

PolyPid Ltd. reichte ein Form 6-K vom 13. August 2025 ein und stellte darin seine ungeprüften, verkürzten Zwischenabschlüsse sowie die Erörterung und Analyse des Managements für die sechs Monate zum 30. Juni 2025 zur Verfügung. Die Einreichung enthält XBRL-formatierte Finanzinformationen, die verkürzte konsolidierte Zwischenbilanz, Gewinn- und Verlustrechnung, Eigenkapitalveränderungsrechnung, Kapitalflussrechnung und Anhang abdecken, sowie eine eingebettete interaktive Titelseitendatei. Der Bericht wurde vom Chief Executive Officer eingereicht und nennt die zugehörigen Ausstellungsnummern für die Finanzberichte, MD&A und das XBRL-Tagging.

Positive
  • Unaudited interim condensed financial statements for the six months ended June 30, 2025 are furnished
  • Management's Discussion and Analysis (MD&A) for the six months ended June 30, 2025 is included
  • XBRL-formatted financial information (balance sheets, operations, equity, cash flows, notes) is provided
  • Cover Page Interactive Data File is embedded to improve accessibility
Negative
  • None.

Insights

TL;DR: Routine Form 6-K furnishing interim financials and MD&A; provides XBRL data for investor review.

The filing is a standard disclosure delivering PolyPid's unaudited interim condensed financial statements and accompanying MD&A for the six-month period ended June 30, 2025. The inclusion of XBRL-tagged financials and an embedded interactive cover page improves accessibility and machine-readability of the financial data. There are no operational metrics, earnings figures or transaction details in the excerpt provided, so material financial conclusions cannot be drawn from this text alone.

TL;DR: Corporate disclosure appears compliant and appropriately executed for a Form 6-K submission.

The document lists exhibits and confirms submission by the Chief Executive Officer, consistent with routine reporting practices for a foreign issuer furnishing interim results. The filing references XBRL formatting and the MD&A, which supports transparency. The excerpt contains no governance actions, leadership changes, or material transactions to assess beyond disclosure completeness.

PolyPid Ltd. ha presentato un Modulo 6-K datato 13 agosto 2025, fornendo i suoi bilanci interinali abbreviati non revisionati e la relazione e analisi della direzione per i sei mesi terminati il 30 giugno 2025. La segnalazione include informazioni finanziarie in formato XBRL che coprono gli stati patrimoniali consolidati interinali abbreviati, i rendiconti economici, il prospetto del patrimonio netto, il rendiconto finanziario e le note, oltre a un file dati interattivo della pagina di copertina incorporato. Il rapporto è presentato dall'Amministratore Delegato e riporta i numeri di riferimento degli allegati relativi ai bilanci, alla MD&A e al tagging XBRL.

PolyPid Ltd. presentó un Formulario 6-K con fecha 13 de agosto de 2025, proporcionando sus estados financieros interinos condensados no auditados y la discusión y análisis de la gerencia correspondientes a los seis meses concluídos el 30 de junio de 2025. La presentación incluye información financiera en formato XBRL que abarca balances consolidados interinos condensados, estados de resultados, patrimonio de los accionistas, flujos de efectivo y notas, además de un Archivo de Datos Interactivo de la Página de Portada incrustado. El informe lo presenta el Director Ejecutivo y lista los números de los anexos relacionados con los estados financieros, la MD&A y el etiquetado XBRL.

PolyPid Ltd.ëŠ� 2025ë…� 8ì›� 13ì¼ìž Form 6-Kë¥� 제출하여 2025ë…� 6ì›� 30ì¼ë¡œ 종료ë˜ëŠ” 6개월 기간ì—� 대í•� 검토ë˜ì§€ ì•Šì€ ì¤‘ê°„ 요약 ìž¬ë¬´ì œí‘œì™¶Ä ê²½ì˜ì§„ì˜ ë…¼ì˜ ë°� ë¶„ì„(MD&A)ì� 제공했습니다. 해당 서류ì—는 중간 요약 ì—°ê²° 대차대조표, ì†ìµê³„ì‚°ì„�, ìžë³¸ ë³€ë™í‘œ, 현금í름í‘� ë°� 주ì„ì� í¬í•¨í•� XBRL 형ì‹ì� ìž¬ë¬´ì •ë³´ì™¶Ä í¬í•¨ë� 표지 페ì´ì§€ ì¸í„°ëž™í‹°ë¸� ë°ì´í„� 파ì¼ì� í¬í•¨ë˜ì–´ 있습니다. 보고서는 최고경ì˜ìžê°€ 제출했으ë©� 재무제표, MD&A ë°� XBRL 태깅 ê´€ë � 전시ë¬� 번호ë¥� 명시하고 있습니다.

PolyPid Ltd. a déposé un formulaire 6-K daté du 13 août 2025, fournissant ses états financiers intermédiaires condensés non audités et la discussion et analyse de la direction pour les six mois clos le 30 juin 2025. le dépôt comprend des informations financières au format XBRL couvrant les bilans consolidés intermédiaires condensés, les comptes de résultat, les capitaux propres, les flux de trésorerie et les notes, ainsi qu'un fichier de données interactif de la page de couverture intégré. Le rapport est soumis par le directeur général et indique les numéros des annexes relatifs aux états financiers, à la MD&A et au balisage XBRL.

PolyPid Ltd. reichte ein Form 6-K vom 13. August 2025 ein und stellte darin seine ungeprüften, verkürzten Zwischenabschlüsse sowie die Erörterung und Analyse des Managements für die sechs Monate zum 30. Juni 2025 zur Verfügung. Die Einreichung enthält XBRL-formatierte Finanzinformationen, die verkürzte konsolidierte Zwischenbilanz, Gewinn- und Verlustrechnung, Eigenkapitalveränderungsrechnung, Kapitalflussrechnung und Anhang abdecken, sowie eine eingebettete interaktive Titelseitendatei. Der Bericht wurde vom Chief Executive Officer eingereicht und nennt die zugehörigen Ausstellungsnummern für die Finanzberichte, MD&A und das XBRL-Tagging.

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the Month of: August 2025 (Report No. 3)

 

Commission File Number: 001-38428

 

PolyPid Ltd.

(Translation of registrant’s name into English)

 

18 Hasivim Street

Petach Tikva 495376, Israel

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

 

☒ Form 20-F      ☐ Form 40-F

 

 

 

 

 

 

CONTENTS

 

This Report of Foreign Private Issuer on Form 6-K consists of PolyPid Ltd.’s (the “Company”): (i) Unaudited Interim Condensed Consolidated Financial Statements as of June 30, 2025, which is attached hereto as Exhibit 99.1; and (ii) Management’s Discussion and Analysis of Financial Condition and Results of Operations for the six months ended June 30, 2025, which is attached hereto as Exhibit 99.2.

 

The contents of this Form 6-K are incorporated by reference into the Company’s registration statements on Form F-3 (File No. 333-276826, File No. 333-280658, File No. 333-281863, File No. 333-284376 and File No. 333-289034) and Form S-8 (File No. 333-239517, File No. 333-271060, File No. 333-277703, File No. 333-280662 and File No. 333-289570) filed with the Securities and Exchange Commission to be a part thereof from the date on which this report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.

 

1

 

 

EXHIBIT INDEX

 

Exhibit No.    
     
99.1   PolyPid Ltd.’s Unaudited Interim Condensed Financial Statements as of June 30, 2025.
99.2   PolyPid Ltd.’s Management’s Discussion and Analysis of Financial Condition and Results of Operation for the Six Months Ended June 30, 2025.
101   The following financial information from the Registrant’s Unaudited Interim Condensed Financial Statements as of June 30, 2025, formatted in XBRL (eXtensible Business Reporting Language): (i) Interim Condensed Consolidated Balance Sheets, (ii) Interim Condensed Consolidated Statements of Operations, (iii) Interim Condensed Consolidated Statements of Shareholders’ Equity; (iv) Interim Condensed Consolidated Statements of Cash Flows, and (v) Notes to Interim Condensed Consolidated Financial Statements.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  POLYPID LTD.
     
Date: August 13, 2025 By: /s/ Dikla Czaczkes Akselbrad
    Name:  Dikla Czaczkes Akselbrad
    Title: Chief Executive Officer

 

3

 

FAQ

What did PolyPid (PYPD) file in this Form 6-K?

The company furnished its unaudited interim condensed financial statements and MD&A for the six months ended June 30, 2025, and XBRL-tagged financials.

Which financial schedules are included in the XBRL data?

The XBRL information covers interim condensed consolidated balance sheets, statements of operations, shareholders' equity, cash flows and notes.

When was the Form 6-K submitted?

The filing is dated August 13, 2025 and is presented as submitted by the Chief Executive Officer.

Does the excerpt contain actual earnings or revenue numbers?

No. The provided excerpt lists exhibits and XBRL items but does not include specific earnings, revenue or other numeric financial results.

Does this filing indicate any material transactions or governance changes?

No. The excerpt contains no information about transactions, leadership changes, or material events beyond the interim financial disclosures.
Polypid Ltd.

NASDAQ:PYPD

PYPD Rankings

PYPD Latest News

PYPD Latest SEC Filings

PYPD Stock Data

55.48M
7.11M
25.65%
49.04%
0.64%
Biotechnology
Healthcare
Israel
Petah Tikva